Nasdaq grts.
Financials. GRTS has a market cap of $169mn and a cash balance of $153mn. Research and development expenses were $30.5 million for the three months ended March 31, 2023 while general and ...
Nov 7, 2023 · About Gritstone bio Gritstone bio, Inc. (Nasdaq: GRTS) is a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines. We leverage our innovative vectors and ... Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.EMERYVILLE, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. Gritstone bio, Inc. Common Stock (GRTS) Pre-Market Stock Quotes - Nasdaq offers ...
Feb 10,2023 - GRTS STOCK PRICE DECREASE: Gritstone bio Inc on 02-10-2023 decreased stock price > 10% from $3.26 to $2.90. Dec 15,2022 - GRTS STOCK PRICE INCREASE: Gritstone bio Inc on 12-15-2022 increased stock price > 10% from $3.11 to $3.92. Dec 14,2022 - GRTS STOCK PRICE INCREASE: Gritstone bio Inc on 12-14 …Gritstone bio ( NASDAQ: GRTS) uses its vaccine technology to promote an immune response against a patients cancer or to prevent or treat infectious disease. In late September, 2023, GRTS announced ...
Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.In the last trading session, 1.12 million Gritstone Bio Inc (NASDAQ:GRTS) shares changed hands as the company’s beta touched 0.61. With the company’s per share price at $1.89 changed hands at -$0.06 or -3.08% during last session, the market valuation stood at $175.92M. GRTS’s last price was a
marketbeat.com - July 5 at 5:00 AM. Gritstone bio (NASDAQ:GRTS) shareholders have endured a 70% loss from investing in the stock three years ago. finance.yahoo.com - July 4 at 10:02 AM. Board Member at Gritstone Bio Acquires Company Stock Options Worth 51,800 Shares. benzinga.com - June 22 at 11:42 PM.Apr 19, 2021 · The big shareholder groups in Gritstone Oncology, Inc. (NASDAQ:GRTS) have power over the company. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to have ... The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings. Price Target Upside/Downside. According to ...As of March 2015, Theranos is a private company and does not have a public stock symbol. The medical technology company has a partnership with the public company, Walgreens, which has a stock symbol of WAG on Nasdaq.Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.
Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.
Second Quarter 2023 Financial Results. Cash, cash equivalents, marketable securities and restricted cash were $122.3 million as of June 30, 2023, compared to $185.2 million as of December 31, 2022 ...
About Latest Pre-Market Trades. Nasdaq provides market information before market opens daily from 4:15 A.M. ET to 7:30 A.M. ET on the following day. You can practice and explore trading GRTS stock methods without spending real money on the virtual paper trading platform. Webull offers GRTS Ent Holdg (GRTS) historical stock prices, in-depth market analysis, NASDAQ: GRTS real-time stock quote data, in-depth charts, free GRTS options chain data, and a fully built financial calendar to help you ...(Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world's most potent vaccines, today announced ... 24 days ago ...Stock analysis for Gritstone bio Inc (GRTS:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.Insiders seem to have made the most of their holdings by selling US$221k worth of Gritstone bio, Inc. (NASDAQ:GRTS) stock at an average sell price of US$22.10 during the past year. The company's ...
3 วันที่ผ่านมา ... Gritstone bio, Inc. Common Stock (GRTS) · GRTS Option $5.00 May 17, 2024.Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. Gritstone ...Gritstone bio's $785 million collaboration for HIV therapies has quantified the value of EDGE more than any Wall Street analyst could ever do. Gilead has already given GRTS $30 million upfront and ...The latest price target for . Gritstone Bio (NASDAQ: GRTS) was reported by Piper Sandler on Thursday, September 28, 2023.The analyst firm set a price target for 7.00 expecting GRTS to rise to ...EMERYVILLE, Calif., July 05, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...
Mar 10, 2022 · Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.
GRTS Historical Data. Get up to 10 years of daily historical stock prices & volumes. The "Close/Last" is the “adjust consolidated close price”. Data provided by Edgar Online . The net and ...Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases. Gritstone ...Gritstone bio (NASDAQ:GRTS) and Citius Pharmaceuticals (NASDAQ:CTXR) are both small-cap medical companies, but which is the superior stock?We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership.Gritstone bio (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.EMERYVILLE, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...Find out why GRTS stock is a Hold. ... (NASDAQ:GRTS) in the spotlight. The company is advancing its pipeline on several fronts, has a collaboration deal with a well-known drug maker, and its lead ...
Latest Gritstone bio Inc (GRTS:NSQ) share price with interactive charts, historical ... GRTS:NSQNASDAQ; Germany; 2JQ:FRAFrankfurt Stock Exchange · 2JQ:DEUGerman ...
Simon is currently serving on the Board of Directors of Gritstone Oncology (NASDAQ: GRTS) and Sientra (NASDAQ:SIEN). Mr. Simon received a BS degree in ...
EMERYVILLE, Calif., Dec. 15, 2022 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company that aims to develop the world’s most potent vaccines, today ...EMERYVILLE, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...Verizon, Walgreens, and 4 Other Stocks. The S&P 500's Best Payouts: 7%+ Dividend Yields. Get the latest GRTS (GRTS) real-time quote, historical performance, charts, and other financial...Jan 9, 2022 · Insiders seem to have made the most of their holdings by selling US$221k worth of Gritstone bio, Inc. (NASDAQ:GRTS) stock at an average sell price of US$22.10 during the past year. The company's ... Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of cancer immunotherapies to fight multiple cancer types. Gritstone develops its ...Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of cancer immunotherapies to fight multiple cancer types. Gritstone develops its ...Gritstone Bio Inc (NASDAQ:GRTS) trade information Instantly GRTS was in red as seen at the end of in last trading. With action -4.35%, the performance over the …WebGritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company, is developing the next generation of immunotherapies against multiple cancer types and infectious diseases.
The average trading volume of GRTS on November 15, 2023 was 2.18M shares. GRTS) stock’s latest price update. Gritstone Bio Inc (NASDAQ: GRTS)’s stock price has gone rise by 8.72 in comparison to its previous close of 1.37, however, the company has experienced a -11.86% decrease in its stock price over the last five trading days.EMERYVILLE, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today ...GRTS Latest Real Time Trades. Select time range to see more trades: Last 100 Trades. NLS Time (ET) NLS Price. NLS Share Volume. 16:00:04. $ 2.64. 861.WebInstagram:https://instagram. u sotckhow to invest in project kuiper stockapgaxbest app for options trading Celebrations may be in order for Gritstone bio, Inc. (NASDAQ:GRTS) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company. The analysts have ...Gritstone bio, Inc. (NASDAQ:GRTS) is an American healthcare company that develops treatments for cancer and other diseases. It is another highly rated stock on our list since the average rating is ... schwab versus fidelitystocks voo Nov 24, 2023 · Gritstone bio (NASDAQ:GRTS) and Citius Pharmaceuticals (NASDAQ:CTXR) are both small-cap medical companies, but which is the superior stock?We will compare the two companies based on the strength of their earnings, risk, community ranking, profitability, media sentiment, valuation, analyst recommendations, dividends and institutional ownership. Gritstone bio, Inc. Common Stock (GRTS) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Web platinum group metals stock The average price predicted for Gritstone Bio Inc (GRTS) by analysts is $10.40, which is $9.08 above the current market price. The public float for GRTS is 87.55M, and at present, short sellers hold a 9.62% of that float. On November 30, 2023, the average trading volume of GRTS was 2.33M shares. The electric vehicle boom is accelerating – …Nov 4, 2023 · Gritstone Bio Inc (NASDAQ:GRTS) trade information. After registering a 2.73% upside in the last session, Gritstone Bio Inc (GRTS) has traded red over the past five days. The stock hit a weekly high of 2.0200 this Friday, 11/03/23, jumping 2.73% in its intraday price action. The 5-day price performance for the stock is -0.53%, and -21.99% over ...